The role of dialysis in contrast-induced nephropathy: doubts and certainties.
Over past years, there has been a progressive increase in percutaneous endovascular procedures in patients with chronic renal disease, owing to the high incidence of vascular disease, particularly coronary artery disease, in this population. The use of contrast media may further worsen renal function in such patients, in some cases even accelerating the progression towards end-stage renal failure, and may increase patient morbidity and mortality. In this review, we discuss the role of dialysis in preventing contrast-induced nephropathy as well as present indications to its use in patients already on dialysis treatment undergoing diagnostic or therapeutic procedures with contrast medium injection.
Division of Nephrology, Civic Hospital, Legnano, MI, Italy. carlo.guastoni@ao-legnano.it
Carlo
C
Guastoni
Stefano
S
De Servi
Marco
M
D'Amico
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control*; D003287:Contrast Media / Q000009:adverse effects* / Q000493:pharmacokinetics; D018450:Disease Progression; D006440:Hemofiltration; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000628:therapy*; D008657:Metabolic Clearance Rate; D011859:Radiography; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000628:therapy*; D014652:Vascular Diseases / Q000150:complications / Q000000981:diagnostic imaging* / Q000378:metabolism
D003287:Contrast Media